Benchmark analyst Robert Wasserman downgrades Danaher (NYSE:DHR) from Buy to Hold.
Owl Creek Urges Cano Health Board To Consider Potential Sale
Owl Creek Asset Management L.P. sent a letter to Cano Health Inc (NYSE: CANO) board
Benchmark Downgrades Danaher to Hold
Benchmark analyst Robert Wasserman downgrades Danaher (NYSE:DHR) from Buy to Hold.
Related Posts
Tesla Granted U.S. Patent #11,440,376 Technologies for Manifolds
https://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=5990&f=G&l=50&d=PTXT&p=120&S1=20220913&OS=20220913&RS=20220913
Coca-Cola Q4 Earnings Preview: Weighing Iconic Brand Strength Against Health Trends, Weight Loss Drug Impact
Coca-Cola to report Q4 earnings on Feb. 13. Analysts focus on market share, competition from weight loss drugs, and company's adaptability.
Satya Nadella’s Move To Hire Sam Altman Wins Universal Praise And Some ‘Revenge Of Clippy’ Humor
Satya Nadella's swift moves to scoop up Sam Altman, and his former OpenAI colleagues have won praise, and also a stream of memes.